|
Sequence |
|
MLPVNSPMNK GDTEVMKCIV EVISDTLSKP SPMPVSQECF ETLRGDERIL SILRHQNLLK ELQDLALQGA KERAHQQKKH SGFEDELSEV LENQSSQAEL KEAVEEPSSK DVME
|
|
Concentration |
|
1 mg/ml (determined by Bradford assay)
|
|
Substrate/Buffer |
|
Liquid. In 20 mM Tris-HCl buffer (pH 8.0) containing 10% glycerol. Endotoxin Level: < 1.0 EU per 1 μg of protein (determined by LAL method )
|
|
Storage |
|
Can be stored at +4°C short term (1-2 weeks). For long term storage, aliquot and store at -20°C or -70°C. Avoid repeated freezing and thawing cycles
|
|
References |
|
Tota BW., et al. (2008). Curr Med Chem. 15(14):1444-51
Blois A., et al. (2006). Requl pept. 134(1):30-7
|
|
Contents/Specifications |
|
Recombinant human Vasostatin 2 protein was expressed in E.coli and purified by using conventional chromatography techniques
|
|
Notes |
|
Vasostatin 2 is the N-terminal fragment (19-131 aa) derived from the cleavage of chromogranin A (CgA) which is a member of the chromogranin/secretogranin(granins) family of neuroendocrine secretory proteins. Vasostatin 2 has been shown to exert several biological activities on several tissues and organs and exerts a large spectrum of homeostatic actions, including antifungal and antimicrobial effect, modulation of cell adhesion, and inhibition of parathyroid hormone secretion.
|